Literature DB >> 25225245

Antigenic variation of TprK facilitates development of secondary syphilis.

Tara B Reid1, Barbara J Molini2, Mark C Fernandez2, Sheila A Lukehart3.   

Abstract

Although primary syphilis lesions heal spontaneously, the infection is chronic, with subsequent clinical stages. Healing of the primary chancre occurs as antibodies against outer membrane antigens facilitate opsonophagocytosis of the bacteria by activated macrophages. TprK is an outer membrane protein that undergoes antigenic variation at 7 variable regions, and variants are selected by immune pressure. We hypothesized that individual TprK variants escape immune clearance and seed new disseminated lesions to cause secondary syphilis. As in human syphilis, infected rabbits may develop disseminated secondary skin lesions. This study explores the nature of secondary syphilis, specifically, the contribution of antigenic variation to the development of secondary lesions. Our data from the rabbit model show that the odds of secondary lesions containing predominately TprK variant treponemes is 3.3 times higher than the odds of finding TprK variants in disseminated primary lesions (odds ratio [OR] = 3.3 [95% confidence interval {CI}, 0.98 to 11.0]; P = 0.055) and that 96% of TprK variant secondary lesions are likely seeded by single treponemes. Analysis of antibody responses demonstrates significantly higher antibody titers to tprK variable region sequences found in the inoculum compared to reactivity to tprK variant sequences found in newly arising secondary lesions. This suggests that tprK variants escape the initial immune response raised against the V regions expressed in the inoculum. These data further support a role for TprK in immune evasion and suggest that the ability of TprK variants to persist despite a robust immune response is instrumental in the development of later stages of syphilis.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25225245      PMCID: PMC4249288          DOI: 10.1128/IAI.02236-14

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  43 in total

1.  Inoculation syphilis in human volunteers.

Authors:  H J MAGNUSON; E W THOMAS; S OLANSKY; B I KAPLAN; L DE MELLO; J C CUTLER
Journal:  Medicine (Baltimore)       Date:  1956-02       Impact factor: 1.889

2.  The tprK gene is heterogeneous among Treponema pallidum strains and has multiple alleles.

Authors:  A Centurion-Lara; C Godornes; C Castro; W C Van Voorhis; S A Lukehart
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

3.  The rate of development and degree of acquired immunity in experimental syphilis.

Authors:  H J MAGNUSON; B J ROSENAU
Journal:  Am J Syph Gonorrhea Vener Dis       Date:  1948-09

4.  Complete genome sequence and annotation of the Treponema pallidum subsp. pallidum Chicago strain.

Authors:  Lorenzo Giacani; Brendan M Jeffrey; Barbara J Molini; HoaVan T Le; Sheila A Lukehart; Arturo Centurion-Lara; Daniel D Rockey
Journal:  J Bacteriol       Date:  2010-03-26       Impact factor: 3.490

5.  Longitudinal data analysis for discrete and continuous outcomes.

Authors:  S L Zeger; K Y Liang
Journal:  Biometrics       Date:  1986-03       Impact factor: 2.571

6.  Quantitative analysis of tpr gene expression in Treponema pallidum isolates: Differences among isolates and correlation with T-cell responsiveness in experimental syphilis.

Authors:  Lorenzo Giacani; Barbara Molini; Charmie Godornes; Lynn Barrett; Wesley Van Voorhis; Arturo Centurion-Lara; Sheila A Lukehart
Journal:  Infect Immun       Date:  2006-10-09       Impact factor: 3.441

7.  Bifunctional role of the Treponema pallidum extracellular matrix binding adhesin Tp0751.

Authors:  Simon Houston; Rebecca Hof; Teresa Francescutti; Aaron Hawkes; Martin J Boulanger; Caroline E Cameron
Journal:  Infect Immun       Date:  2010-12-13       Impact factor: 3.441

8.  Opsonic potential, protective capacity, and sequence conservation of the Treponema pallidum subspecies pallidum Tp92.

Authors:  C E Cameron; S A Lukehart; C Castro; B Molini; C Godornes; W C Van Voorhis
Journal:  J Infect Dis       Date:  2000-04-13       Impact factor: 5.226

9.  Function and protective capacity of Treponema pallidum subsp. pallidum glycerophosphodiester phosphodiesterase.

Authors:  C E Cameron; C Castro; S A Lukehart; W C Van Voorhis
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

10.  Current status of syphilis vaccine development: need, challenges, prospects.

Authors:  Caroline E Cameron; Sheila A Lukehart
Journal:  Vaccine       Date:  2013-10-14       Impact factor: 3.641

View more
  20 in total

1.  Reduced Treponema pallidum-Specific Opsonic Antibody Activity in HIV-Infected Patients With Syphilis.

Authors:  Christina M Marra; Lauren C Tantalo; Sharon K Sahi; Shelia B Dunaway; Sheila A Lukehart
Journal:  J Infect Dis       Date:  2015-12-09       Impact factor: 5.226

Review 2.  The Treponema pallidum Outer Membrane.

Authors:  Justin D Radolf; Sanjiv Kumar
Journal:  Curr Top Microbiol Immunol       Date:  2018       Impact factor: 4.291

3.  Transcription of TP0126, Treponema pallidum putative OmpW homolog, is regulated by the length of a homopolymeric guanosine repeat.

Authors:  Lorenzo Giacani; Stephanie L Brandt; Wujian Ke; Tara B Reid; Barbara J Molini; Stefanie Iverson-Cabral; Giulia Ciccarese; Francesco Drago; Sheila A Lukehart; Arturo Centurion-Lara
Journal:  Infect Immun       Date:  2015-03-23       Impact factor: 3.441

Review 4.  Treponema pallidum, the syphilis spirochete: making a living as a stealth pathogen.

Authors:  Justin D Radolf; Ranjit K Deka; Arvind Anand; David Šmajs; Michael V Norgard; X Frank Yang
Journal:  Nat Rev Microbiol       Date:  2016-10-10       Impact factor: 60.633

5.  M. tuberculosis T Cell Epitope Analysis Reveals Paucity of Antigenic Variation and Identifies Rare Variable TB Antigens.

Authors:  Mireia Coscolla; Richard Copin; Jayne Sutherland; Florian Gehre; Bouke de Jong; Olumuiya Owolabi; Georgetta Mbayo; Federica Giardina; Joel D Ernst; Sebastien Gagneux
Journal:  Cell Host Microbe       Date:  2015-11-11       Impact factor: 21.023

6.  A Retrospective Study on Genetic Heterogeneity within Treponema Strains: Subpopulations Are Genetically Distinct in a Limited Number of Positions.

Authors:  Darina Čejková; Michal Strouhal; Steven J Norris; George M Weinstock; David Šmajs
Journal:  PLoS Negl Trop Dis       Date:  2015-10-05

Review 7.  Novel Treponema pallidum Recombinant Antigens for Syphilis Diagnostics: Current Status and Future Prospects.

Authors:  Aleksey Kubanov; Anastassia Runina; Dmitry Deryabin
Journal:  Biomed Res Int       Date:  2017-04-24       Impact factor: 3.411

8.  Characterizing the Syphilis-Causing Treponema pallidum ssp. pallidum Proteome Using Complementary Mass Spectrometry.

Authors:  Kara K Osbak; Simon Houston; Karen V Lithgow; Conor J Meehan; Michal Strouhal; David Šmajs; Caroline E Cameron; Xaveer Van Ostade; Chris R Kenyon; Geert A Van Raemdonck
Journal:  PLoS Negl Trop Dis       Date:  2016-09-08

9.  A non-healing syphilid: Another face of the great imitator.

Authors:  Gabriel Anid; Michael Isaac; Carla R Penner; Paul Van Caeseele; Raymond S W Tsang; Kamran Kadkhoda
Journal:  IDCases       Date:  2017-02-11

Review 10.  Mini-review: Strategies for Variation and Evolution of Bacterial Antigens.

Authors:  Janet Foley
Journal:  Comput Struct Biotechnol J       Date:  2015-07-26       Impact factor: 7.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.